CoChat

Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives

Open access
Farrer, Lindsay A., Adrienne Cupples, L., Van Duijn, Cornelia M., Kurz, Alexander, Zimmer, Reinhilde, Müller, Ulrich, Green, Robert C., Clarke, Valerie, Shoffner, John, Wallace, Douglas C., Chui, Helena, Flanagan, Steven D., Duara, Ranjan, George‐Hyslop, Peter St., Auerbach, Sanford A., Volicer, Ladislav, Wells, John M., Van Broeckhoven, Christine, Growdon, John H., Haines, Jonathan L. · 1995 · Annals of Neurology
Cited by 100

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Numerous studies have shown that the risk of Alzheimer's disease (AD) is associated with the dose of the ϵ4 allele of apolipoprotein E (ApoE). However, more than one third of AD patients lack ϵ4 and many persons having ϵ4 survive cognitively intact to old age. We evaluated the lifetime risk of disease in 3,999 first‐degree relatives of 549 probands who met the criteria for probable or definite AD and whose ApoE genotypes were known. ApoE genotypes for relatives were not determined. After age 65 the risk among relatives was proportional, as much as 7 to 10% at age 85, to the number of ϵ4 alleles present in the proband. Risks to relatives of ApoE 2/2 and 2/3 probands were nearly identical at all ages to risks for relatives of ApoE 3/3 probands. The expected proportion of relatives having at least one ϵ4 allele was calculated for each genotype group based on the distribution of parents, sibs, and offspring in the sample. Among relatives in the ApoE 3/3 group, the lifetime risk for AD by age 90 was three times greater than the expected proportion of ϵ4 carriers, suggesting that factors other than ApoE contribute to AD susceptibility. Furthermore, the 44% risk of AD by age 93 among relatives of ApoE 4/4 probands indicates that as many as 50% of people having at least one ϵ4 allele do not develop AD. We also found that among male relatives, risk of AD in the ApoE 3/4 group was similar to that for the ApoE 3/3 group but significantly less than the risk for the ApoE 4/4 group. In contrast, among female relatives the risk for the ApoE 3/4 group was nearly twice that for the ApoE 3/3 group and identical to the risk for the ApoE 4/4 group. These findings are consistent with a sex‐modification effect of the E4 isoform on disease susceptibility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.410380515

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 100

Metadata

Authors
Farrer, L. A., Adrienne Cupples, L., Van Duijn, C. M., Kurz, A., Zimmer, R., Müller, U., Green, R. C., Clarke, V., Shoffner, J., Wallace, D. C., Chui, H., Flanagan, S. D., Duara, R., George‐Hyslop, P. S., Auerbach, S. A., Volicer, L., Wells, J. M., Van Broeckhoven, C., Growdon, J. H., & Haines, J. L.
Venue
Annals of Neurology
Publisher
Wiley
Published
1995-11
Volume
38
Issue
5
Pages
797-808
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2068377076
Cited by
100
References
14
FWCI
4.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives. https://app.cochat.ai/papers/10.1002/ana.410380515
The paper
Farrer, L. A., Adrienne Cupples, L., Van Duijn, C. M., Kurz, A., Zimmer, R., Müller, U., Green, R. C., Clarke, V., Shoffner, J., Wallace, D. C., Chui, H., Flanagan, S. D., Duara, R., George‐Hyslop, P. S., Auerbach, S. A., Volicer, L., Wells, J. M., Van Broeckhoven, C., Growdon, J. H., & Haines, J. L. (1995). Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives. Annals of Neurology. https://doi.org/10.1002/ana.410380515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.